Treatment guidelines for managing anaphylaxis in children should be reassessed, according to a new Canadian study published in the Journal of Allergy and Clinical Immunology: In Practice. Involving ...

ARLINGTON HEIGHTS, Ill. – (December 18, 2023) — Two new practice parameters from the Joint Task Force for Practice Parameters (JTFPP) offer evidence-based recommendations for the diagnosis and ...

New guidelines on the management of anaphylaxis from the European Academy of Allergy and Clinical Immunology (EAACI) underscore the need to use intramuscular epinephrine as first-line treatment. The ...

Please provide your email address to receive an email when new articles are posted on . Current guidelines have not been validated in infants and toddlers. Overlooked symptoms include flushing, ...

Treatment guidelines for managing anaphylaxis in children should be reassessed, according to a new Canadian study published in the Journal of Allergy and Clinical Immunology: In Practice. Involving ...

Please provide your email address to receive an email when new articles are posted on . Based on response, patients may not need to visit the ED after using an epinephrine autoinjector. The authors ...

A groundbreaking consensus report on anaphylaxis – the severe reaction some people experience from bee stings, peanut butter exposures, medications, and the like – has been released by the Global ...

Anaphylaxis is rare but serious — It’s a severe allergic reaction that can happen suddenly and progress quickly Triggers vary and can include foods, medications, insect stings and latex Epinephrine ...

The main treatment for anaphylaxis is epinephrine, usually given by injection. If you don’t have access to epinephrine, call 911 or seek emergency care immediately. The most effective way to manage ...

The new 'Idiopathic Anaphylaxis Yardstick' will help physicians who might be searching for guidance on next steps after their patient has an anaphylactic reaction of an unknown origin. Many people in ...

Two new practice parameters from the Joint Task Force for Practice Parameters (JTFPP) offer evidence-based recommendations for the diagnosis and management of anaphylaxis and atopic dermatitis (AD) in ...